Beata Kołodziej

Nicolaus Copernicus University — Poland

Medicine · Health Sciences

6h-index158citations34works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(19), Acute Myeloid Leukemia Research(11), Chronic Myeloid Leukemia Treatments(8), Childhood Cancer Survivors' Quality of Life(7), Chronic Lymphocytic Leukemia Research(6)

Publications34 total

Differential in Vitro Drug Resistance Profile Between First and Second Relapsed Acute Lymphoblastic Leukemia and Acute Myeloblastic Leukemia in Children

Blood·2015

Phenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia

10 cited

Medicine·2015· 10 citedOpen Access

IN VITRO DRUG RESISTANCE IN CHILDHOOD MATURE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Medical and Biological Sciences·2014Open Access

Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia.

6 cited

PubMed·2012· 6 cited

Patterns of Individual Tumor Response Testing (ITRT) and Bone Marrow Minimal Residual Disease (MRD) On Day 15 of Therapy in Childhood Precursor-B-Lineage Acute Lymphoblastic Leukemia (ALL): MRD and Ex Vivo Drug Resistance Have Similar Predictive Value of Relapse.

1 cited

Blood·2012· 1 cited

Individualized tumor response testing profile has a prognostic value in childhood acute leukemias: multicenter non-interventional long-term follow-up study

2 cited

Leukemia & lymphoma/Leukemia and lymphoma·2012· 2 citedOpen Access

Bcr-Abl Amplification Plays a Major Role in Resistance to Tyrosine Kinase Inhibitors in K-562 Cell Line

1 cited

2012· 1 cited

Differential ex vivo drug resistance profile in first and subsequent relapsed childhood acute myeloid leukemia in comparison to initial diagnosis

Medical and Biological Sciences·2012

Bcr-Abl Amplification Plays a Major Role in Resistance to Tyrosine Kinase Inhibitors in K-562 Cell Line

Medical and Biological Sciences·2012

Differential ex vivo drug resistance profile in first and subsequent relapsed childhood acute myeloid leukemia in comparison to initial diagnosis

1 cited

Medical and Biological Sciences·2012· 1 cited

Bortezomib has little ex vivo activity in chronic myeloid leukemia: individual tumor response testing comparative study in acute and chronic myeloid leukemia

1 cited

Współczesna Onkologia·2012· 1 citedOpen Access

Usuwanie arsenu w procesach membranowych

2012

Individualized Tumor Response Testing (ITRT) Profile Has a Prognostic Value in Childhood Acute Lymphoblastic Leukemia (ALL) and Acute Non-Lymphoblastic Leukemia (ANLL): The Multicenter Non-Interventional Long-Term Follow-up Study of Polish Pediatric Leukemia Study Group

Blood·2011

Prognostic value of persistent peripheral blood and bone marrow lymphoblasts on day 15 of therapy in childhood acute lymphoblastic leukemia as detected by flow cytometry.

9 cited

PubMed·2011· 9 cited

Differential activity of nelarabine and clofarabine in leukaemia and lymphoma cell lines

Contemporary Oncology/Współczesna Onkologia·2010

Bortezomib Has No. Ex Vivo Activity in Chronic Myeloid Leukemia: Individual Tumor Response Testing Comparative Study in Pediatric and Adult Acute and Chronic Leukemia.

Blood·2009

[KIR-NKAT2 expression and monocytoid dendritic cells transformation in children diagnosed for immune deficiency: a pilot study].

PubMed·2009

Changes in the MDR1 gene expression after short-term ex vivo therapy with prednisolone have prognostic impact in childhood acute lymphoblastic leukemia

1 cited

Annals of Hematology·2009· 1 citedOpen Access

Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemia.